Home/Filings/4/0001764013-25-000163
4//SEC Filing

Van Tuyl Christopher 4

Accession 0001764013-25-000163

CIK 0001764013other

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 4:05 PM ET

Size

56.4 KB

Accession

0001764013-25-000163

Insider Transaction Report

Form 4
Period: 2025-12-18
Van Tuyl Christopher
Chief Legal Officer
Transactions
  • Sale

    Common Stock

    2025-12-18$26.78/sh8,529$228,407152,214 total
  • Sale

    Common Stock

    2025-12-18$27.38/sh2,284$62,536149,930 total
Footnotes (3)
  • [F1]On December 16, 2024, the holder was granted 109,956 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on December 18, 2024, of which 27,489 of these RSUs vested on December 16, 2025. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
  • [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.23 - $27.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
  • [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.25 - $27.52 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Issuer

Immunovant, Inc.

CIK 0001764013

Entity typeother

Related Parties

1
  • filerCIK 0001779707

Filing Metadata

Form type
4
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:05 PM ET
Size
56.4 KB